Overview

A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of Ceftaroline 600 mg when administered by varying infusion volumes.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Pfizer
Treatments:
Ceftaroline fosamil
Cephalosporins